SouthState Corp’s Cardiol Therapeutics CRDL Stock Holding History

SouthState Corp’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$1.07K	–	1362
2025 Q3	$1.07K	Hold	1,000	–	–	﹤0.01%	1048
2025 Q2	$1.36K	Hold	1,000	–	–	﹤0.01%	1192
2025 Q1	$970	Hold	1,000	–	–	﹤0.01%	1348
2024 Q4	$1.28K	Hold	1,000	–	–	﹤0.01%	647
2024 Q3	$1.98K	Hold	1,000	–	–	﹤0.01%	570
2024 Q2	$2.02K	Hold	1,000	–	–	﹤0.01%	595
2024 Q1	$1.81K	Hold	1,000	–	–	﹤0.01%	618
2023 Q4	$843	Hold	1,000	–	–	﹤0.01%	574
2023 Q3	$895	Hold	1,000	–	–	﹤0.01%	598
2023 Q2	$890	Hold	1,000	–	–	﹤0.01%	571
2023 Q1	$487	Hold	1,000	–	–	﹤0.01%	632
2022 Q4	$510	Buy	+1,000	New	+$610	﹤0.01%	681

Other funds holding CRDL

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SouthState Corp's CRDL Position: Q4 2025 in Review

SouthState Corp sold out of Cardiol Therapeutics (CRDL) in Q4 2025, closing a stake of 1,000 shares — an estimated $1.07K sold.

SouthState Corp first reported a position in CRDL in Q4 2022 and held it in 12 quarters. The position peaked at $2.02K in Q2 2024. 41 funds tracked by Wall St. Rank hold CRDL as of Q4 2025.

SouthState Corp reported no remaining Cardiol Therapeutics position as of Q4 2025 after selling out during the quarter.
SouthState Corp sold 1,000 Cardiol Therapeutics shares in Q4 2025, an estimated $1.07K.
SouthState Corp first reported a position in Cardiol Therapeutics in Q4 2022 and held it in 12 quarters.
SouthState Corp's Cardiol Therapeutics position peaked at $2.02K in Q2 2024.
41 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q4 2025.

Based on SouthState Corp's 13F filing for Q4 2025, filed 11 Feb 2026.